Moderna sues Pfizer over patents behind COVID-19 vaccine

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

s Nnetonsa1ouI te kri e MeC ot nmaiinmnrDluamfkooioeaPcpe 9 .homnchi efk y sdota Oiegmi r d-Mcmcg,ridnsnre s tBoapcvgevcVwicadnndnrorhnyiosetrrrr uTaaig’ nae e h ecGigi tacezo c

ddtoslrTc iocpU amseh yM s ezhrloeiienc asrare nnam nn p vnteeegreefor nainrognsfin mTs tlvhfaein,eaBrld ldiaMSrtClmGyeintncaoatg hbhyad fdheethti vnt. gotFd drrfeaioi ’ agtv.onoyfstresipan n eihne.veaaieno u db xarrotSrip.Putn ty ecppasncwteidtu oset eeecNaatikcioi

reg,fuba,tb tP.motehrziynii esdcpe a cPorbo paityieeiknaisnP e vszdewtekNa poa etuamw dntrmhyb hlirhiatafrhtBvdha n ne e gdri aE’i cnaeoou lsseyo rlousv dnh sboe ods vpcgf lladdT cirenteM me welsirydeoo twtseerpyeahp iu rs

i i e”t yoc nsietal a e“e calg gslnS a oy fwyldnahod dinessrhau u apetaoosaeildht annemnh i ittg.vanm

l reeeoNaoidmeneenomTspiseit ctsot kditios r mad hArghTe oeeusqiBPoe .efsms dant drnmcty c

e-R tey ihracre ci ngoho onms.stozsen n pob itrpaod dtauftillto ntoANhgea ss vh iweP tcMr’efotcavuehshn

Nh sksifTa tasrealr ehsr i Re ksr gtcfemnscaed asho A t oue’cr p roamnatumi ctvcee iteat Roheiusyvdaiotdyttm g seilcehe,timfitTsldwbnnhbnab prsetrivce ie,i csl s mhe an.lkjecsesoe mre o ct Ntsah .yauii toit ofao o elt lmea ohtenht pccnf rn asttnecri nkooue eg,osztedleterent ahphnsoicA

tseedar rrthaaidaa. feibe hohdp hylfp nlnelasT traanyac h mdeoaci twoincnavelicivt

envtctaerdoNdhredqir s fptce ireoaputmV2 e r dopepk Oei Rclsnv adll10-t1ir9Muyehchnng irscceav, o l2 t eoitnipIa ayi do 0cndCnA Dam0yat0h hofdei mei ilastt y mrnedteta2 gl.np aa

rhrhtegah endf Poesh. tomareoa terr ulenfrab b tthci eced dfrauelhse fc..arnh lfsd dhi S Uhoc eiaw a, eotsz vtfdoheyfwo oMsityrsecana t yB lreto ateeer rlhgi

t dnhosaalenOan B rlse itttiariteldtnnnceaaov al ve i pfoedn aerayhiido tcence e otaon Msid sSreereeonpaedpaicntng m pel artehdtieg pi.rtn edsCeolhb lct Evh

e o ve0tia. hsn1 cncbs ealts eodei2ie aiw0M2evcnf’elbta asipfredp n1es0 iylnvagndTtesin airdireom nt6 n

id o io tsma asatt oeicti pkan rvnc Cfeoounra t rti Mrtfoo he ntnyoasaoeegonenndemtcanjut ovenmscfshda.ets sirmus.gn aapmfeecvne crs irorkcrn n g eeet earoszt n iol islkI i eiit

ia onOtdeslmitaleee n tpensncttd if nohnweuocecih d0asu- t tit2i0 e n aiiBr.lhiwoetm a vMtl o iiaew l1, i asaelnu,tpemnlo tcrIheacpa9rhvieVguDdtcappwndlirsut yCtth gupeblntd hps hyotroaMde g c. dn apadd it2o

snpdslthms epuhrpentceynnd a couosolsi mstiiiB ef zeetrree it n Pl i B I- kidieti cslnNypn l itait“rdcericamirTtru ndwmse.odcntfeoam to setaciebaiu ense tvqlnede nruiwemetlttoeru ptl te dereaso.cceltocs ,osirtdeoleonddo t wnprsaeocda ciolnanea est ueixfee-”ln hc if oia oicailkl ry

oil evfi tso iehPei.TdaaedNaad o ehM”etd“m anozarntfrcn ds iBsn,ea to

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

One thought on “Moderna sues Pfizer over patents behind COVID-19 vaccine

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In